Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of American Academy of Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7673494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease.

  1994cited by this paper
• Control of fibrosis in systemic scleroderma.

  1993cited by this paper
• Autoantibodies directed against different classes of Fc gamma R are found in sera of autoimmune patients.

  1993cited by this paper
• An Fc gamma RIII (CD16)-specific autoantibody from a patient with progressive systemic sclerosis.

  1993cited by this paper
• Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma.

  1992cited by this paper
• Autoimmune mice make anti-Fc gamma receptor antibodies

  1990cited by this paper
• Autoantibodies in scleroderma.

  1989cited by this paper
• Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration.

  1989cited by this paper
• A STRATEGY FOR DETERMINING THE PATHOGENESIS OF SYSTEMIC SCLEROSIS: Is Transforming Growth Factor β the Answer?

  1989cited by this paper
• Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells

  1988cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.

  1987cited by this paper
• Blockade of clearance of immune complexes by an anti-F(cγ) receptor monoclonal antibody

  1986cited by this paper
• Scl 70 antibody—a specific marker of systemic sclerosis

  1986cited by this paper
• Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.

  1984cited by this paper
• NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases.

  1983cited by this paper
• Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis.

  1982cited by this paper
• Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

  1980cited by this paper
• Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.

  1979cited by this paper
• Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance.

  1979cited by this paper
• Cellular infiltrates in scleroderma skin.

  1977cited by this paper

• Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis

  2023cites this paper
• Serum levels of anti‐Fcγ receptor IIB/C antibodies are increased in patients with systemic sclerosis

  2014cites this paper
• Antigen-Presenting Cells and their Fcγ and Toll-Like Receptors: Leading Suspects in Autoimmunity

  2010cites this paper
• Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR)

  2010cites this paper
• The of Rheumatology Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Correction: Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A

  2010cites this paper
• Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata.

  2007cites this paper
• [Antireceptor and antichannel autoantibodies].

  2006cites this paper
• Localized scleroderma is an autoimmune disorder.

  2005cites this paper
• Epidemiology and pathogenesis of scleroderma

  2003cites this paper
• Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.

  2002cites this paper
• Anti-fibroblast antibodies in systemic sclerosis.

  2002cites this paper
• Immunopathogenesis of scleroderma--evolving concepts.

  2001cites this paper
• Decreased Fcgamma receptor III (CD16) expression on peripheral blood mononuclear cells in patients with Sjögren's syndrome.

  1998cites this paper